investorscraft@gmail.com

Intrinsic Value of CTI BioPharma Corp. (CTIC)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-12-31 and quarterly data as of 2023-03-31.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %1512.8NaN
Revenue, $54NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m134NaN
Operating income, $m-80NaN
EBITDA, $m-78NaN
Interest expense (income), $mNaN
Earnings before tax, $m-93NaN
Tax expense, $m0NaN
Net income, $m-93NaN

BALANCE SHEET

Cash and short-term investments, $m80NaN
Total assets, $m126NaN
Adjusted assets (=assets-cash), $m46NaN
Average production assets, $m13NaN
Working capital, $m18NaN
Total debt, $m109NaN
Total liabilities, $m144NaN
Total equity, $m-18NaN
Debt-to-equity ratio-6.206NaN
Adjusted equity ratio-1.078NaN

CASH FLOW

Net income, $m-93NaN
Depreciation, amort., depletion, $m2NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-81NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m0NaN
Free cash flow, $m-81NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m18
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount